Temporary supply shortage of Tamiflu® (oseltamivir phosphate) 6 mg/mL Powder for Oral Suspension
Roche Products Pty Limited (Australia) would like to inform you of a temporary supply shortage of Tamiflu® (oseltamivir phosphate) 6 mg/mL Powder for Oral Suspension, with their next delivery planned in early August 2024. This shortage is due to an unexpected increase in demand. While Tamiflu 6 mg/mL Powder for Oral Suspension is in short supply, Tamiflu 30 mg, 45 mg and 75 mg Capsules continue to be available.
Roche are working to minimise the duration and impact of the shortage and are closely monitoring demand during this time of limited supply. Current information about the shortage is available on the Therapeutic Goods Administration’s Medicine Shortage Reports Database at apps.tga.gov.au/prod/MSI/search.
If your usual wholesaler is unable to supply Tamiflu 6 mg/mL Powder for Oral Suspension, we recommend that you check availability with an alternative wholesaler.
If Tamiflu 6 mg/mL Powder for Oral Suspension is not available, Tamiflu suspension can be prepared from Tamiflu capsules at the pharmacy or at home. Instructions are available below at Tamiflu Product Information.
Roche are working to minimise the duration and impact of the shortage and are closely monitoring demand during this time of limited supply. Current information about the shortage is available on the Therapeutic Goods Administration’s Medicine Shortage Reports Database at apps.tga.gov.au/prod/MSI/search.
If your usual wholesaler is unable to supply Tamiflu 6 mg/mL Powder for Oral Suspension, we recommend that you check availability with an alternative wholesaler.
If Tamiflu 6 mg/mL Powder for Oral Suspension is not available, Tamiflu suspension can be prepared from Tamiflu capsules at the pharmacy or at home. Instructions are available below at Tamiflu Product Information.
